When you run your own in house pharmacy it reminded me of day trading. You were constantly looking for the "hot stock" or in this instance the top few drugs that had the highest profit margins. There was never much rhyme or reason to it. But I remember for topical androgel e.g. we would pay like $300 for a bottle and the insurance companies would reimburse us like $700. But for something like phenergan? We would pay $10 and get reimbursed something like $11. I think memantine had a great profit margin. Pharmacy is a miasma but on the whole this is true: if you do a lot of prescribing, and there are ~5 or more docs in the practice, you should have your own in house pharmacy. An in house pharmacy will NEVER make sense for a pure rad onc group (almost no matter how big they are).